Jacquier, Arnaud
Risson, Valérie
Simonet, Thomas
Roussange, Florine
Lacoste, Nicolas
Ribault, Shams
Carras, Julien
Theuriet, Julian
Girard, Emmanuelle
Grosjean, Isabelle
Le Goff, Laure
Kröger, Stephan
Meltoranta, Julia
Bauché, Stéphanie
Sternberg, Damien
Fournier, Emmanuel
Kostera-Pruszczyk, Anna
O’Connor, Emily
Eymard, Bruno
Lochmüller, Hanns
Martinat, Cécile
Schaeffer, Laurent http://orcid.org/0000-0001-6600-503X
Funding for this research was provided by:
AFM-Téléthon (strategic grant MyoNeurALP, MyoPharm grant, grant ID 20030)
Agence Régionale de Santé Auvergne-Rhône-Alpes (Master 2 grant)
Association pour le Développement de la Neurogénétique (CMT grant)
Fondation de la Recherche Medicale (equipe FRM)
Fondation pour la Recherche Médicale (M2R202106013343)
Société Francophone du Nerf Périphérique (master grant)
Canadian Institutes of Health Research (Foundation Grant FDN-167281)
Muscular Dystrophy Canada (Network Catalyst Grant for NMD4C)
Canada Foundation for Innovation (CFI-JELF 38412)
Canada Research Chairs (in Neuromuscular Genomics, Health, 950-232279)
Article History
Received: 1 February 2022
Revised: 25 July 2022
Accepted: 25 July 2022
First Online: 10 August 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (DC-2012–1535 and AC-2012–1536). Samples’ collection was realized in accordance with national and European regulations (Article L1243-3 and L1243-4). Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.